Neil will spearhead the expansion of the drug discovery and development team at Healx.N eil brings over 30 years of experience in the biotech and pharmaceutical industries and has a background working across a breadth of disease areas. Across his three-decades-long career, he has been involved in progressing more than 10 drugs into patients and has led a number of drug discovery projects across a variety of therapeutic areas.

Commenting on his appointment, Dr Neil Thompson, CSO of Healx, said: “Healx’s novel approach of using AI to start with the patient as opposed to a target, is what first drew me to the company. I am excited to bring my experience to this leading AI-powered biotech that is helping patients with rare diseases. I am tremendously proud of the accomplishments to date, notably those I made during my time at Astex, and look forward to drawing on those experiences to build a team of dynamic, forward-thinking scientists, as we work to achieve our goal of progressing treatments to the clinic that can make a real difference to lives of patients.”